Total

CMV reactivation

no reactivation

p-value

   

n

%

n

%

n

%

 
Total included  

22

 

14

 

8

   
Sex male

11

50

8

57

3

38

0,659

  female

11

50

6

43

5

63

 
Age (years) median (range)

56

(18-66)

58

(19-66)

52

(18-61)

0,165

Diagnosis AML

8

36

5

36

3

38

0,423

  MM

5

23

2

14

3

38

 
  NHL

6

27

5

36

1

13

 
  Hodgkin

1

5

1

7

0

0

 
  ALL

1

5

1

7

0

0

 
  MDS

1

5

0

0

1

13

 
HLA mismatch  

2

9

2

14

0

0

0,515

Donor related

17

77

11

79

6

75

1,000

  unrelated

5

23

3

21

2

25

 
Conditioning nma

19

86

13

93

6

75

0,527

  ma

3

14

1

7

2

25

 
ATG  

7

32

4

29

3

38

1,000

CMV serostatus R+/D+

8

36

8

57

0

0

0,010

  R+/D-

9

41

5

36

4

50

 
  R-/D+

5

23

1

7

4

50

 

R-/D-

0

0

0

0

0

0


AML: Acute Myeloid Leukemia; MM: Multiple Myeloma; NHL: Non-Hodgkin Lymphoma; ALL: Acute Lymphatic Leukemia; MDS: Myelodysplastic Syndrome; NMA: Nonmyeloablative; MA: Myeloablative; ATG: Anti-thymocyte Globulin; CMV: Cytomegalovirus; SCT: Stem Cell Transplantation
Differences between groups were compared using the Fisher’s Exact test in case of discrete variables. In case of continues variables the Mann-Whitney test was used.
Table 1: Patient characteristics.